Pharmacovigilance Risk Assessment Committee (PRAC)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
gptkb:parliamentary_committee |
| gptkbp:abbreviation |
gptkb:PRAC
|
| gptkbp:advisorTo |
gptkb:European_Parliament
gptkb:EU_Member_States gptkb:European_Medicines_Agency |
| gptkbp:establishedIn |
2012
|
| gptkbp:focus |
safety of medicines
benefit-risk assessment |
| https://www.w3.org/2000/01/rdf-schema#label |
Pharmacovigilance Risk Assessment Committee (PRAC)
|
| gptkbp:jurisdiction |
gptkb:European_Union
|
| gptkbp:location |
gptkb:Amsterdam
gptkb:Netherlands |
| gptkbp:mainLanguage |
English
|
| gptkbp:meetingPlace |
monthly
|
| gptkbp:parentOrganization |
gptkb:European_Medicines_Agency
|
| gptkbp:partOf |
gptkb:European_Medicines_Agency
|
| gptkbp:responsibleFor |
pharmacovigilance
risk assessment of medicinal products |
| gptkbp:reviewedBy |
adverse drug reactions
|
| gptkbp:website |
https://www.ema.europa.eu/en/committees/prac
|
| gptkbp:bfsParent |
gptkb:EMA_(Europe)
|
| gptkbp:bfsLayer |
7
|